Picture of the day: digest of the main news from May 30, 2025
Main
#1 The Russian Ministry of Health has approved a new list of criteria for assessing the quality of medical care under the compulsory medical insurance. Despite a broad public discussion of the draft regulation, the final version included only specific amendments by the regulator for certain nosologies. The system of assessing quality using the “fulfilled/not fulfilled” formula, criticized by experts, without an emphasis on treatment results, remained without adjustments, and the terms of medical care were not included in the regulation. The massive 656-page document will come into force on September 1, 2025, and will become the basis for compulsory medical insurance auditors to conduct assessments of the quality of medical care in conjunction with current clinical recommendations, which became the basis for updating the order.
#2 The General Meeting of the Russian Academy of Sciences summed up the results of the elections for academicians and corresponding members. Natalia Manturova, Chief Plastic Surgeon of the Russian Ministry of Health, was elected as a Corresponding Member of the RAS from the Department of Medical Sciences. Olga Kobyakova, Director of the Central Research Institute of Oncology and Immunology of the Ministry of Health, and Alexander Kolsanov, Rector of the Samara State Medical University, were elected to the vacancy of a Corresponding Member with an age limit. Among others, Natalia Mokrysheva, Director of the National Medical Research Center of Endocrinology, and Sergei Petrikov, Director of the N.V. Sklifosovsky Research Institute of the Moscow Department of Health, were elected as Academicians of the RAS. A total of 20 Academicians and 31 Corresponding Members of the RAS were elected to the specialized department. 64 and 163 candidates, respectively, were nominated for the vacancies from the Department of Medical Sciences of the RAS.
Incidents
Zamoskvoretsky District Court of Moscow placed Alexey Sazonov, head of the Department of Regulation of Circulation of Medicines and Medical Devices of the Ministry of Health of the Russian Federation, under house arrest. He is suspected under Part 6 of Article 290 of the Criminal Code of the Russian Federation (accepting a bribe on an especially large scale). Parsad Singh Shashi Shankar, director of the Indian Jodas Expoim, was also taken into custody for two months under the same article. Law enforcement officials have not officially disclosed the details of the case or the amount of the alleged bribe. At the same time, the media noted that the top manager of Jodas Expoim allegedly wanted to negotiate with representatives of the Ministry of Health so that the regulator would not revoke the registration of the manufacturer's drugs. At the same time, it became known about the cancellation of state registration of the drug of the Indian pharmaceutical company for the treatment of type II diabetes - Semaglutide G and ten other drugs .
Medical products market
The Russian Ministry of Health will update the Procedure for maintaining the register of clinical trials of medical devices. The new regulations will replace two orders of Roszdravnadzor adopted in 2013 and 2014. According to the new version of the procedure, the register will contain the date and number of permission to conduct a clinical trial of a medical device, the name, NCMI, potential risk class of use, information about the manufacturer and authorized representative, place of production, information about the clinical trials, including information about the clinics where they were conducted, as well as the status of the clinical trial itself. Manufacturers and authorized companies will be able to submit data on the start and completion of trials through the public services portal. As before, the register will be publicly available on the official website of Roszdravnadzor.
Pharmaceutical business
The Akselpharm company challenged the FAS order to transfer 567 million rubles to the state budget. In the fall, the regulator found the pharmaceutical company to have violated the Law on Protection of Competition due to the launch of a generic drug for the treatment of non-small cell lung cancer Tagrisso (osimertinib) from the British-Swedish AstraZeneca. The Moscow Arbitration Court found the FAS actions illegal. The Vademecum pharmaceutical company reported that the now overturned decision was made by the antimonopoly service on November 20, 2024.
Criminal cases
The Pyatigorsk City Court of the Stavropol Territory extended the detention of the former head of the National Medical Research Center for Rehabilitation and Balneology Anatoly Fesyun by three months, until August 23, 2025. The Bloknot Stavropol portal reports that Fesyun is suspected of abuse of office, which resulted in damages in the amount of 160 million rubles. Among the possible defendants in the case are representatives of the Gorny Vozdukh and Rossiya sanatoriums. Investigators believe that Fesyun issued licenses for rehabilitation in the direction of neurology to a number of local sanatoriums, where patients with moderate restrictions were treated as "severe", and funding from the compulsory medical insurance fund was received in an increased amount.
Infrastructure
A center for medical innovations and bioengineering will be organized at the Russian Scientific Center of Surgery named after Academician B.V. Petrovsky. 2.914 billion rubles will be allocated from the federal budget for these purposes. The technical specifications indicate that the facility should ensure technological sovereignty and priority for Russia in creating a system of new methods for diagnosing serious diseases using human cellular and subcellular objects. The center's key competencies should be knowledge-intensive models for obtaining biotechnological drugs, their production, as well as the analysis of omics technologies and molecular genetic testing.
Other news:
The Ministry of Labor approved the professional standard "Tester of rehabilitation products"
vademec
